Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel ...

Milk Makeup and Obagi's Parent Company Acquires Injectables Company

Waldencast, which owns Milk Makeup and Obagi Medical, has acquired medical aesthetics brand Novaestiq. As part of the deal, Waldencast also obtained the U.S. rights to the brand's hyaluronic acid injectable gel line, Saypha, which is currently seeking the U.S. Food and Drug Administration's approval. Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand [press r…

Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast

/PRNewswire/ -- Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced the acquisition of Novaestiq Corp. by Waldencast...

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel ...

Acquisition strengthens Obagi Medical’s product portfolio with proven, scientifically backed, injectable portfolio

Obagi, Milk Makeup Owner Waldencast Enters Filler Market With New Acquisition

Waldencast acquires Novaestiq and U.S. rights to Saypha hyaluronic acid injectables, aiming to offer comprehensive skin care and injectable solutions.

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Acquisition strengthens Obagi Medical’s product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi...

Waldencast Acquires Novaestiq Corp. and US Rights to Saypha Dermal Fillers

The acquisition significantly expands Obagi Medical’s portfolio beyond medical-grade skin care into the U.S. dermal filler market.